Dyne Therapeutics CEO Joshua Brumm's 2022 pay rises 6% to $4.3M
Dyne Therapeutics reports 2022 executive compensation
By ExecPay News
Published: April 7, 2023
Dyne Therapeutics reported fiscal year 2022 executive compensation information on April 7, 2023.
In 2022, four executives at Dyne Therapeutics received on average a compensation package of $2.9M, a 1% increase compared to previous year.
Average pay of disclosed executives at Dyne Therapeutics
Joshua Brumm, Chief Executive Officer, received $4.3M in total, which increased by 6% compared to 2021. 40% of Brumm's compensation, or $1.7M, was in stock awards. Brumm also received $336K in non-equity incentive plan, $1.7M in option awards, $610K in salary, as well as $996 in other compensation.
Josh Brumm, Chief Executive Officer, received a compensation package of $4.3M. 40% of the compensation package, or $1.7M, was in stock awards.
Susanna High, Chief Operating Officer, earned $1.6M in 2022, a 6% decrease compared to previous year.
Oxana Beskrovnaya, Chief Scientific Officer, received $1.5M in 2022, which decreases by 49% compared to 2021.
Related executives
You may also like
Source: SEC filing on April 7, 2023.